Pharmacy benefit managers (PBMs) have recently come under fire as Congress works to lower prescription drug costs in the United States. While prescription drugs often get blamed for high premiums and costs, one industry report found that for every dollar, 11 cents is spent on brand-name medicines – while up to 20 cents is going toward administrative costs.

Healthcare entities see significant profits from their PBM subsidiaries via their mail-order and specialty pharmacies and clinical programs. This system will keep many of these companies in the Fortune 50 while prescriptions become increasingly expensive for employers and patients. There's a reason the major insurance companies and PBMs are now combined entities: There's big money in working the system to their own benefit.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.